GHRS · GH Research PLC
United States · RS rating 37 · As of 2026-10-14
| Price | 18.56 USD |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 5 / 9 / 87 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 34 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +25.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.4% |
| Market cap (USD) | $1.2B |